22
SHARING INTELLIGENCE WORLD NEWS
Reducing the threat of counterfeit drugs is the latest topic for TAPA APAC’s supply chain resilience podcast series
TAPA APAC has launched a Supply Chain Resilience Podcast focusing on trending topics relating to supply chain resilience and sustainability. Each episode will feature exclusive discussions with guest speakers from leading supply chain and logistics providers, offering listeners key insights, strategies and updates.
The latest podcast featured Ramesh Raj, Regional Manager of the Pharmaceutical Security Institute (PSI), who shared his views and supply chain resilience knowledge on the highly topical issue of reducing the growing threats posed by counterfeit drugs.
With the surge in demand for pharmaceutical products to contain the spread of coronavirus, there have been multiple reports of counterfeit drugs and thefts of healthcare products across the world. Ramesh Raj highlighted the impact of coronavirus and the challenges faced by the pharmaceutical industry in terms of product thefts, security issues and counterfeit products. “Having an end-to-end supply chain visibility system which helps to avoid infiltration and security breaches is the key fundamental strategy. Companies must align anti-counterfeiting strategies to their corporate supply chain
strategies while focusing on supply chain monitoring,” he stated.
Tony Lugg, Chairman of TAPA APAC, added: “We couldn’t be more excited to share meaningful insights from industry experts and to bring further awareness to supply chain resilience. The podcast will allow TAPA to start engaging our members and listeners on-the- go worldwide in a more interactive way. Our next two episodes are already in production.”
New podcast episodes will be released on TAPA APAC’s website and members can listen to all episodes at any time. To listen to the latest episode, click here
Members can provide feedback and ideas for future podcast topics, or offer to become a guest contributor by contacting
marketing@tapa-apac.org.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28
